Jacqueline S. Garcia

Boston University — United States

Medicine · Health Sciences

34h-index6.3kcitations377works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(208), Chronic Myeloid Leukemia Treatments(108), Myeloproliferative Neoplasms: Diagnosis and Treatment(88), Hematopoietic Stem Cell Transplantation(55), Cancer Genomics and Diagnostics(41)

Publications377 total

Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML
Blood Advances·2025Open Access
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide
UNC Libraries·2025Open Access
Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
2025Open Access
Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
2025Open Access
Table S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
2025Open Access
Table S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
2025Open Access
Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
2025Open Access
Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
2025Open Access
Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
2025Open Access
Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
2025Open Access
American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults
Blood Advances·2025Open Access
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide
Blood Cancer Journal·2025Open Access
Table S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates
2025Open Access
Supplementary Protocol from A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i>-Mutated Myeloid Malignancies
2025Open Access
Supplementary Tables and Figures from A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i>-Mutated Myeloid Malignancies
2025Open Access
Early persistence of recipient stem-cells and T-cell dysregulation are associated with relapse after transplant in AML/MDS
2025Open Access
Tagraxofusp, azacitidine, and venetoclax (TAG-AZA-VEN) triplet therapy shows efficacy, tolerability, and transplant potential in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): Results of a phase 2 trial
Blood·2025Open Access
Ven+FluBu2 with ptcy/tac/MMF RIC transplant followed by venetoclax/azacitidine maintenance for high-risk MDS/AML
Blood·2025· 1 citedOpen Access
Temporal multiomic profiling reveals intrinsic resistance mechanisms to ERK inhibition in relapsed Acute Myeloid Leukemia
Blood·2025Open Access
Venetoclax plus inotuzumab ozogamicin for relapsed and refractory ALL: Results of a phase I trial
Blood·2025Open Access
page 1 of 19Next →

Frequent Co-authors

Richard M. Stone(15), Marina Konopleva(13), Daniel J. DeAngelo(13), Donna Neuberg(11), Guillermo Garcia‐Manero(10), Wan‐Jen Hong(9), Marlise R. Luskin(9), Brian A. Jonas(8), Anthony Letai(8), Pierre Fenaux(8), Jalaja Potluri(8), Courtney D. DiNardo(7), Ying Zhou(7), Robert J. Soiffer(7), Eric S. Winer(7), Naval Daver(7), Olatoyosi Odenike(7), Andrew H. Wei(6), Michael Andreeff(6), Ilene Galinsky(6)